ARIPIPRAZOLE and INSOMNIA

Overview

INSOMNIA is the #10 most commonly reported adverse reaction for ARIPIPRAZOLE, manufactured by Otsuka America Pharmaceutical, Inc.. There are 3,817 FDA adverse event reports linking ARIPIPRAZOLE to INSOMNIA. This represents approximately 1.8% of all 209,896 adverse event reports for this drug.

Patients taking ARIPIPRAZOLE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INSOMNIA is a less commonly reported adverse event for ARIPIPRAZOLE, but still significant enough to appear in the safety profile.

Other Side Effects of ARIPIPRAZOLE

In addition to insomnia, the following adverse reactions have been reported for ARIPIPRAZOLE:

• DRUG INEFFECTIVE — 8,139 reports
• WEIGHT INCREASED — 7,698 reports
• OFF LABEL USE — 7,392 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 5,248 reports
• ANXIETY — 4,991 reports
• FATIGUE — 4,187 reports
• SUICIDAL IDEATION — 3,991 reports
• DEPRESSION — 3,950 reports
• NAUSEA — 3,904 reports
• TREMOR — 3,610 reports

Other Drugs Associated with INSOMNIA

The following drugs have also been linked to insomnia in FDA adverse event reports:

Does ARIPIPRAZOLE cause INSOMNIA?

INSOMNIA has been reported as an adverse event in 3,817 FDA reports for ARIPIPRAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INSOMNIA with ARIPIPRAZOLE?

INSOMNIA accounts for approximately 1.8% of all adverse event reports for ARIPIPRAZOLE, making it a notable side effect.

What should I do if I experience INSOMNIA while taking ARIPIPRAZOLE?

If you experience insomnia while taking ARIPIPRAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages